A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Intention |
---|---|
Submitter | Austria |
Regulatory programme |
|
CLP Annex VI Index Number |
|
Classification
Harmonised classification at the time of the proposal |
|
---|---|
Proposed harmonised classification by the dossier submitter |
|
Intention timeline
Date of intention | 2019-10-07 |
---|---|
Expected date of submission | 2019-12-31 |
Documents
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
Jan. 14, 2020
- Harmonised classification at the time of the proposal: Aquatic Acute 1, H400
- Proposed harmonised classification by the dossier submitter: Aquatic Acute 1, H400
- Proposed specific concentration limits by the dossier submitter: Oral: ATE = 401 mg/kg Dermal: ATE = 467 mg/kg Inhalation: ATE = 1.47 mg/L (vapours)
- Status: Intention → Submitted
- Submitted for accordance check: 2019-12-19
Feb. 25, 2020
- CLH report: https://echa.europa.eu/documents/10162/e39a7523-143a-fb8c-c8e7-65330f5b33b8
- Deadline for commenting: 2020-04-24
- Final submission date: 2020-02-03
- Hazard classes open for commenting: Acute Toxicity - inhalation Acute Toxicity - dermal Acute Toxicity - oral
- Legal deadline for opinion adoption: 2021-08-04
- Status: Submitted → Opinion Development
- Start of consultation: 2020-02-24
May 7, 2020
- Comments received: https://echa.europa.eu/documents/10162/dc071496-25c3-434f-11fe-a2bd8fd8bf2a
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/982e67e9-af2c-2ece-8654-2e62e77f4a37
March 27, 2021
- Name: Allyl methacrylate → 2-methyl-2-propenoic acid 2-propenyl ester;allyl methacrylate
April 6, 2021
- Date of opinion: 2021-03-18
- Status: Opinion Development → Opinion Adopted
April 9, 2021
- Name: 2-methyl-2-propenoic acid 2-propenyl ester;allyl methacrylate → Allyl methacrylate
May 17, 2021
- Background document: https://echa.europa.eu/documents/10162/624e3677-3ca3-c288-7fd8-0d896859efa6
- Comments received: https://echa.europa.eu/documents/10162/dc071496-25c3-434f-11fe-a2bd8fd8bf2a → https://echa.europa.eu/documents/10162/28551b37-3a9e-c956-9323-8a7aa85390f5
- RAC opinion: https://echa.europa.eu/documents/10162/0dd2085a-b53c-4135-1eff-7e2abe74c74a
June 7, 2021
- Proposed specific concentration limits by the dossier submitter: Oral: ATE = 401 mg/kg Dermal: ATE = 467 mg/kg Inhalation: ATE = 1.47 mg/L (vapours) → inhalation: ATE = 1,47 mg/L (vapours) dermal: ATE = 467 mg/kg bw oral: ATE = 401 mg/kg bw
This version
Nov. 26, 2019
- Regulatory programme: Chemical registered under REACH
Add the related substance to your watchlist to monitor this regulatory record.